US 6503939
Combination regimens using 3,3-substituted indoline derivatives
expired A61KA61K31/57A61K45/06
Quick answer
US patent 6503939 (Combination regimens using 3,3-substituted indoline derivatives) held by Ligand Pharmaceuticals Incorporated expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/57, A61K45/06, A61P, A61P15/18